Consumers Push to Advance CV Sciences Suit

By Willis Jacobson
Dec 6, 2020
The plaintiffs suing CBD company CV Sciences have asked a federal judge to end an indefinite stay on the suit, arguing that waiting on regulatory clarity from the U.S. Food and Drug Administration (FDA) will not change their claims.Two consumers...

This content is FREE for registered users.

To view this content you need to register as a Weedweek member.

If you are already a member please login below.